|
SLC35A5 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.26799999950111E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.961100E-04 |
| Normal-vs-Stage2 |
7.280100E-03 |
| Normal-vs-Stage3 |
2.37129999969277E-07 |
| Normal-vs-Stage4 |
6.88429999673446E-08 |
| Stage1-vs-Stage2 |
5.467600E-01 |
| Stage1-vs-Stage3 |
1.034230E-02 |
| Stage1-vs-Stage4 |
2.984200E-03 |
| Stage2-vs-Stage3 |
2.454400E-01 |
| Stage2-vs-Stage4 |
1.045830E-01 |
| Stage3-vs-Stage4 |
5.291000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.06050000001379E-06 |
| Normal-vs-AfricanAmerican |
5.40756328604175E-12 |
| Normal-vs-Asian |
4.469800E-01 |
| Caucasian-vs-AfricanAmerican |
3.68689999996619E-06 |
| Caucasian-vs-Asian |
7.530400E-01 |
| AfricanAmerican-vs-Asian |
1.853620E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.31259999536226E-08 |
| Normal-vs-Female |
3.158900E-03 |
| Male-vs-Female |
6.898500E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.735800E-02 |
| Normal-vs-Age(41-60Yrs) |
2.777400E-04 |
| Normal-vs-Age(61-80Yrs) |
8.42239999965244E-08 |
| Normal-vs-Age(81-100Yrs) |
2.26110000001167E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.713200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.890000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.745700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.692200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.704300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.555250E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.015400E-01 |
| Normal-vs-Grade 2 |
1.219670E-02 |
| Normal-vs-Grade 3 |
1.33730000406729E-08 |
| Normal-vs-Grade 4 |
9.30450050340426E-10 |
| Grade 1-vs-Grade 2 |
2.321000E-01 |
| Grade 1-vs-Grade 3 |
2.161300E-03 |
| Grade 1-vs-Grade 4 |
5.422000E-04 |
| Grade 2-vs-Grade 3 |
2.155600E-04 |
| Grade 2-vs-Grade 4 |
4.20410000000482E-05 |
| Grade 3-vs-Grade 4 |
4.068300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.043200E-01 |
| Normal-vs-ccB subtype |
2.10310000525737E-08 |
| ccA subtype-vs-ccB subtype |
1.29439999996261E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.751910E-04 |
| Normal-vs-N1 |
8.417600E-02 |
| N0-vs-N1 |
4.765000E-01 |
|
|
